BioLife Solutions, Inc.
BLFSNASDAQHealthcare● Active
$26.86
+$0.21(+0.79%)
Market Cap$1.3B
P/E Ratio—
52W High$29.62
52W Low$17.86
BioLife Solutions, Inc. (BLFS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BLFS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $96.21M | $82.25M | $75.86M | $76.24M | $119.16M |
| Cost of Revenue | $34.10M | $28.58M | $96.52M | $29.33M | $90.31M |
| Gross Profit | $62.12M | $53.67M | $46.75M | $46.91M | $28.85M |
| Gross Margin %(computed) | 64.56% | 65.25% | 61.63% | 61.53% | 24.21% |
| Operating Expenses | |||||
| R&D Expenses | $7.57M | $7.91M | $18.80M | $14.80M | $11.82M |
| G&A Expenses | $45.52M | $40.54M | $43.26M | $33.26M | $34.10M |
| Total Operating Expenses | $74.25M | $60.80M | $117.58M | $52.83M | $73.34M |
| Operating Income | ($12.13M) | ($7.13M) | ($23.44M) | ($5.92M) | ($35.16M) |
| Operating Margin %(computed) | -12.61% | -8.67% | -30.90% | -7.77% | -29.51% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $2.71M | $0.72M | $1.81M | $0.69M | $0.48M |
| Income Before Tax | ($12.08M) | ($11.43M) | ($18.47M) | ($4.85M) | ($29.03M) |
| Income Tax Expense | $0.05M | ($0.04M) | $0.02M | ($5.24M) | ($20.12M) |
| Net Income | ($12.13M) | ($20.18M) | ($66.43M) | ($139.81M) | ($8.91M) |
| Net Margin %(computed) | -12.61% | -24.54% | -87.57% | -183.38% | -7.48% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.25 | $-0.44 | $-1.52 | $-3.29 | $-0.23 |
| Wtd Avg Shares | 47.75M | 46.07M | 43.72M | 42.48M | 38.50M |
| EBITDA | ($9.38M) | $1.53M | ($45.24M) | ($124.18M) | ($16.65M) |
| EBITDA Margin %(computed) | -9.74% | 1.86% | -59.64% | -162.89% | -13.98% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more BioLife Solutions, Inc. data
About BioLife Solutions, Inc. (BLFS) Income Statement
BioLife Solutions, Inc. (BLFS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BLFS reported revenue of $0.10B, gross profit of $0.06B (gross margin 64.56%), and net income of ($0.01B) — a net profit margin of -12.61%.
Frequently asked questions
BLFS · 4 questionsBioLife Solutions, Inc. (BLFS) reported revenue of $0.10B for 2025, up 17.0% year-over-year.
BLFS revenueBLFS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08